David J Portman MD

CEO, Chief Medical Officer, Sermonix: clinical & research interest in breast cancer, menopause, osteoporosis, and sexual health

[The Conversation - Australia + New Zealand @ConversationEDU]

Democracy demands that citizens are treated equally under the law. The tax avoidance practices of the ultra-rich violate that principle, a new book argues. @ProfCarlRhodes @UTSEngage https://t.co/Sfk0qE4cnJ

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

CLINICAL TRIAL PROTOCOL: ELAINE 3 👉 A phase 3 study of #lasofoxifene plus #abemaciclib to treat ER+/HER2-, ESR1-mutated #MetastaticBreastCancer 🔓https://t.co/Oz0waDJr7m
✍️@mpgoetz @thomas_bachelot @adenonneville @drsarahsam @SherryShenMD @DportmanDavid @tandfonline #MBC #BreastCancer

[dahlia kurtz ✡︎ דליה קורץ @DahliaKurtz]

This is The KiIIing Roads. A documentary so we can bear witness to October 7.

It's being doused with 1-star reviews. YouTube removed it once. It’s back — for now.

They aim to erase history to replace it with twistory. Do not allow this. Please share.
https://t.co/VW1KppAzzS

[David J Portman MD @DportmanDavid]

Exciting quality of life data just published on Sermonix’s investigational lasofoxifene https://t.co/VaEOq7pMUz

[ISSWSH @ISSWSH]

Navigating sexual health after a cancer diagnosis can be challenging, but it is a crucial aspect of overall well-being.

Join us for an enlightening and supportive webinar, "Sexual Health in Women After Cancer Diagnosis."

Register here: https://t.co/EOGtWlYpYH

[David J Portman MD @DportmanDavid]

@drsarahsam @antgiorda Would love to see the other slides on this

[David J Portman MD @DportmanDavid]

@stage4kelly Thinking good thoughts for you Kelly!

[Scientific Network @cancersexnet]

Visit with Sermonix Pharmaceuticals at the 9th Conference of the Scientific Network, April 18-19, 2024 in Columbus, OH. @SermonixPharma #cancersexnet2024

[David J Portman MD @DportmanDavid]

Sermonix is excited to announce our collaboration with Henlius to develop and commercialize investigational oral lasofoxifene in China. Our teams are eager to work together and enroll in the Elaine 3 global trial https://t.co/Vn0JagPONy

[Sermonix Pharmaceuticals @SermonixPharma]

ANNOUNCEMENT! We are pleased to announce the publication of ELAINE-1 and ELAINE-2 trial results in @Annals_Oncology.

Read more in the official press release: https://t.co/TPvzsZbBkE
#BCSM

[Stephanie Graff, MD, FACP, FASCO @DrSGraff]

Lasofoxifene versus fulvestrant for ER+/HER2− metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial - Annals of Oncology https://t.co/TxgIeoTdKT
@OncoAlert @mpgoetz @drsarahsam @StoverLab @ErikaHamilton9 @hoperugo @Annals_Oncology

[David J Portman MD @DportmanDavid]

JCO Precision Oncology just published a durable complete response/remission of over 2 and half years in a patient with metastatic breast cancer on investigational lasofoxifene in Elaine 1 phase 2 trial. https://t.co/oTHu6kMAHc

[David J Portman MD @DportmanDavid]

@drsarahsam What about PD-L1 such as Avelumab in Pace? Any similar concerns? Didn’t hear of hepato-tox issues in that larger sample of patients.

[David J Portman MD @DportmanDavid]

Honored to sponsor and present lasofoxifene data on behalf of Sermonix at the 1st Dava Oncology Breast Cancer Summit among esteemed colleagues and friends in Kona Hawaii

[Paolo Tarantino @PTarantinoMD]

ASCO Guideline Rapid update by @DrHBurstein et al

Routine testing for emergence of ESR1 mut is recommended at recurrence or progression on ET+/-CDK4/6 inhibitor. This should be performed on blood (preferred) or tissue obtained at the time of progression.

https://t.co/FeACvfQlhU

[David J Portman MD @DportmanDavid]

@DrSGraff @SG_BCC @MondialCongress @myESMO @ASCO @DrHBurstein @drdonsdizon @curijoey @stolaney1 See you there!

[David J Portman MD @DportmanDavid]

@JaniceTNBCmets @DrSGraff @Rhodeislandmd @drdonsdizon Guardant 360 CDx does report the ESR1 variants detected. Haven’t seen any data to date on elacestrant’s effects and clinical outcomes for specific ESR1 mutations from Emerald.

[David J Portman MD @DportmanDavid]

@LailaAgrawalMD @Norton_Health @NortonProvider Great program. Please reach out to me to discuss our lead compound lasofoxifene and its potential role in sexual health and breast cancer.

[David J Portman MD @DportmanDavid]

@ASCO @LailaAgrawalMD Great program. Please reach out to me to discuss our lead compound lasofoxifene and its potential role in sexual health and breast cancer.

[David J Portman MD @DportmanDavid]

@silke4senate My deepest condolences. A exceptional woman who will be missed. A privilege to have met her and take a small part during her care.